Investors

AMAG is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people’s lives, all while delivering value to our shareholders.

Headquartered in Waltham, Massachusetts, with locations in Tucson, Arizona, and San Bruno, California, our products support the health of patients in the areas of maternal and women’s health, anemia management and cancer supportive care. In addition, we help families preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders and have the potential to play a valuable role in the ongoing development of regenerative medicine.

Along with driving organic growth of our products, we seek to leverage our existing commercial infrastructure with additional commercial-stage products in our two current therapeutic areas and may consider late-stage development assets or seek opportunities in new therapeutic areas.

Presentation

  AMAG 1Q 2018 Financial Results

2017 Form 10-K and 2018 Proxy Materials

  View the 10-K
  View the Proxy
  View the Proxy Card
  View the Shareholder Letter

Recent Event Webcasts

Webcast ImageWebcast
Q1 2018 AMAG Pharmaceuticals, Inc. Earnings Conference Call (Replay)
May 03, 2018 at 8:00 a.m. ET
Webcast ImageWebcast
AMAG Pharmaceuticals at Deutsche Bank 43rd Annual Health Care Conference (Replay)
May 08, 2018 at 8:40 a.m. ET
Webcast ImageWebcast
AMAG at the Bank of America Merrill Lynch Health Care Conference (Replay)
May 15, 2018 at 4:20 p.m. PT